Trieu Vuong - May 26, 2023 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role
CHAIRMAN AND CEO, Director, 10%+ Owner
Signature
/s/ Trieu, Vuong
Stock symbol
OTLC
Transactions as of
May 26, 2023
Transactions value $
$4,327
Form type
4
Date filed
5/31/2023, 09:39 AM
Previous filing
May 2, 2023
Next filing
Jun 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLC Common Stock Purchase $4.33K +127K +0.14% $0.03 91M May 26, 2023 Direct
holding OTLC Common Stock 16.8M May 26, 2023 By Autotelic, Inc.
holding OTLC Common Stock 6.87M May 26, 2023 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Dr. Trieu purchased 126,888 shares of Oncotelic Therapeutics, Inc., in 5 tranches, in his individual capacity on May 26, 2023 from the open market at an average price of $0.0341.